Desmoplastic Small Round Cell Tumor - 25 Studies Found
Suspended |
: Activated T Cells Armed With GD2 Bispecific Antibody in Children and Young Adults With Neuroblastoma and Osteosarcoma :
|
Suspended |
: Study of High Dose Intravenous (IV) Ascorbic Acid in Measurable Solid Tumor Disease :
: Drug: Enoblituzumab enoblituzumab administered IV weekly for up to 96 weeks |
Active, not recruiting |
: French National Registry of Rare Peritoneal Surface Malignancies :
|
Completed |
: Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin for Children With Peritoneal Cancer :
|
Recruiting |
: Understanding Communication in Healthcare to Achieve Trust (U-CHAT) :
|
Completed |
: Imatinib Mesylate in Treating Patients With Relapsed or Refractory Solid Tumors of Childhood :
|
Not yet recruiting |
: A Phase II of Nivolumab Plus Ipilimumab in Non-resectable Sarcoma and Endometrial Carcinoma :
: |